Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_provenance.
- NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_assertion description "[Dabrafenib joins vemurafenib to confirm the superior clinical outcome of the BRAF inhibitors when compared with dacarbazine in patients with BRAF(V600E)-positive advanced melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_provenance.
- NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_assertion evidence source_evidence_literature NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_provenance.
- NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_assertion SIO_000772 24259661 NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_provenance.
- NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_assertion wasDerivedFrom befree-2016 NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_provenance.
- NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_assertion wasGeneratedBy ECO_0000203 NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1130097.RATPhnvgqWWPy6zYcViXSg1jIN-fNJHEGz4e3dj23zvAQ130_provenance.